Transfection Reagents and Equipment Market by Method & by Application - Analysis & Global Forecast to 2020

Over the years, the transfection reagents and equipment market has witnessed various technological advancements in equipment as well as reagents to address the requirements of researchers and biotechnology and biopharmaceutical companies. These advancements have led to the development of transfection instruments that are of higher efficiency. It has also resulted in efficient quantitative and qualitative transfection in a wide range of cells, including the hard-to-transfect cells.
In 2015, the reagents segment is expected to account for the largest share of the transfection reagents and equipment market, by product; the biochemical method segment is expected to account for the largest share of the global transfection reagents and equipment market, by method; while the biomedical research segment is expected to account for the largest share of the transfection reagents and equipment market, by application.

In 2015, North America is expected to account for the largest share of the global transfection reagents and equipment market, followed by Europe, Asia-Pacific, and rest of the world (RoW). In future, the transfection reagents and equipment market is expected to witness the highest growth rate in the Asia-Pacific region, with emphasis on India, China, and Japan. High growth in these countries can be attributed to the increase in research activities conducted in these regions, rapid expansion of the biotechnology and pharmaceutical industry, government as well as private sector support, increase in cancer incidences, and favorable regulatory framework.

The global transfection reagents and equipment market witnesses’ low competitive intensity as Thermo Fisher Scientific, Inc. (U.S.) occupies majority of the market share. However, several other players and many small firms with similar product offerings are adopting various strategies (agreements, partnerships, joint ventures, collaborations, geographic expansions, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global market.


Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms, to garner a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

‧ Market Penetration: Comprehensive information on product portfolios offered by the top players in the transfection reagents and equipment market. The report analyzes the transfection reagents and equipment market, by product, method, and application

‧ Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the transfection reagents and equipment market

‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various transfection methods across regions

‧ Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the transfection technologies market

‧ Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the transfection reagents and equipment market

TABLE OF CONTENTS

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 22
1.5 LIMITATIONS 22
1.6 STAKEHOLDERS 22
2 RESEARCH METHODOLOGY 23
2.1 RESEARCH METHODOLOGY STEPS 23
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 24
2.2.1 SECONDARY RESEARCH 24
2.2.1.1 Key data from secondary sources 24
2.2.2 PRIMARY RESEARCH 25
2.2.2.1 Key industry insights 26
2.2.2.2 Key data from primary sources 27
2.2.2.3 Key insights from primary sources 28
2.3 MARKET SIZE ESTIMATION METHODOLOGY 28
2.4 MARKET FORECAST METHODOLOGY 30
2.5 MARKET DATA VALIDATION AND TRIANGULATION 31
2.6 ASSUMPTIONS 31
3 EXECUTIVE SUMMARY 32
3.1 INTRODUCTION 32
3.2 CURRENT SCENARIO 34
3.3 FUTURE OUTLOOK 35
3.4 CONCLUSION 37
4 PREMIUM INSIGHTS 38
4.1 GLOBAL TRANSFECTION TECHNOLOGIES MARKET 38
4.2 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION AND REGION 39
4.3 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT (2015 VS. 2020) 40
?
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 42
5.2 MARKET SEGMENTATION 42
5.3 MARKET DYNAMICS 43
5.3.1 DRIVERS 44
5.3.1.1 Growing Research Activities In Cell Science 44
5.3.1.2 Technological Advancements In Transfection Instruments And Reagents 45
5.3.1.3 Rising Incidence of Cancer Worldwide 45
5.3.1.4 Global Alliances Among Leading Research Institutes to Trigger Drug Discovery 45
5.3.2 RESTRAINTS 47
5.3.2.1 High Reliability on Grants Might Restrict Growth 47
5.3.2.2 Selective Effectiveness of Transfection Reagents 47
5.3.3 OPPORTUNITIES 48
5.3.3.1 Large-Scale Transfections likely to propel Transfection Equipment market 48
5.3.3.2 Rising Demand for Protein Therapeutics 48
5.3.3.3 Asian Market Presents High-Growth Opportunities 48
5.3.4 CHALLENGES 50
5.3.4.1 Transfection in hard-to-transfect cells 50
6 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT 51
6.1 INTRODUCTION 52
6.2 REAGENTS 53
6.3 EQUIPMENT/INSTRUMENTS 54
7 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD 55
7.1 INTRODUCTION 56
7.2 BIOCHEMICAL METHODS 57
7.2.1 CALCIUM PHOSPHATE 58
7.2.1.1 Advantages 58
7.2.1.2 Disadvantages 59
7.2.2 LIPOFECTION 59
7.2.2.1 Advantages 60
7.2.2.2 Disadvantages 60
7.2.3 DEAE-DEXTRAN 61
7.2.3.1 Advantages 61
7.2.3.2 Disadvantages 61
7.2.4 DENDRIMERS 62
7.2.4.1 Advantages 62
7.2.4.2 Disadvantages 62
?
7.3 PHYSICAL 63
7.3.1 INTRODUCTION 63
7.3.2 ELECTROPORATION 64
7.3.2.1 Advantages 64
7.3.2.2 Disadvantages 64
7.3.3 NUCLEOFECTION 65
7.3.3.1 Advantages 65
7.3.3.2 Disadvantages 65
7.3.4 OTHER METHODS 66
7.3.4.1 Sonoporation 66
7.3.4.2 Gene Gun 67
7.3.4.2.1 Advantages 67
7.3.4.2.2 Disadvantages 67
7.3.4.3 Magnetofection 67
7.3.4.3.1 Advantages 67
7.3.4.3.2 Disadvantages 68
7.3.4.4 Optoinjection 68
7.3.4.4.1 Advantages 68
7.3.4.4.2 Disadvantages 68
7.4 VIRAL METHODS 69
7.4.1 INTRODUCTION 69
7.4.2 ADVANTAGES 69
7.4.3 LIMITATIONS 69
8 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION 71
8.1 INTRODUCTION 72
8.2 BIOMEDICAL RESEARCH 74
8.2.1 GENE EXPRESSION STUDIES 75
8.2.2 CANCER RESEARCH 76
8.2.3 TRANSGENIC MODELS 77
8.3 PROTEIN PRODUCTION 78
8.4 THERAPEUTIC DELIVERY 79
9 GLOBAL TRANSFECTION TECHNOLOGIES MARKET, BY REGION 81
9.1 INTRODUCTION 82
9.2 NORTH AMERICA 84
9.2.1 U.S. 89
9.2.1.1 Increase in Bio-Based Drug Research 89
9.2.1.2 Growing Demand for Protein-Based Therapeutics Triggers the Growth of U.S. Market 90
9.2.1.3 Growing Funding for Biotechnology and for Development of Protein Based Biologics 90
?
9.2.2 CANADA 93
9.2.2.1 Government Support for Development of Protein Drugs is Expected to Drive the Market for Transfection Technologies 93
9.2.2.2 Increasing Investments by the Canadian Government on Regenerative Medicine to Spur Market Growth 93
9.3 EUROPE 97
9.3.1 GERMANY 102
9.3.1.1 Advances in the Biotechnological & Research Sectors 102
9.3.1.2 Collaboration Among the Bio-Pharmaceutical and Biotechnology Companies for Development of New Vaccines is Likely the Spur the Market Growth 102
9.3.2 U.K. 106
9.3.2.1 Strong Biotechnology Industry 106
9.3.2.2 Increase in R&D Investments 106
9.3.3 FRANCE 109
9.3.3.1 Strong Biotechnology Industry in France 109
9.3.4 REST OF EUROPE (ROE) 113
9.3.4.1 Growing Biotechnology Industry in Italy and Spain 113
9.3.4.2 Investments and Funding for Life Sciences to Bolster the Transfection Technologies Market 113
9.4 ASIA-PACIFIC 117
9.4.1 JAPAN 122
9.4.1.1 Rise in Biomedical Research in Japan 122
9.4.2 CHINA 125
9.4.2.1 Increasing Government and Private Sector Investments in China’s Life Sciences Market 125
9.4.3 INDIA 129
9.4.3.1 Booming Pharmaceutical Industry and Funding for Biotechnology 129
9.4.3.2 Development of Bio-Clusters in India 129
9.4.4 PACIFIC COUNTRIES 133
9.4.4.1 Favourable Regulatory Changes to Increase the Market in New Zealand and Australia 133
9.4.4.2 Federal Collaborations in Australia 133
9.4.5 REST OF ASIA-PACIFIC 136
9.4.5.1 Rising Pharmaceutical and Biotechnology R&D Activities in Korea 136
9.4.5.2 Government Support for Strong Academic and Commercial R&D Activities in Taiwan 137
9.5 REST OF THE WORD (ROW) 140
9.5.1 LATIN AMERICA 140
9.5.1.1 Increasing Investment in Brazil and Mexico 140
9.5.2 MIDDLE EAST AND AFRICA 141
9.5.2.1 Increasing Focus of Major Pharmaceutical, Biopharmaceutical and Biotechnology Firms in Saudi Arabia and the United Arab Emirates (UAE) and African Regions 141
10 COMPETITIVE LANDSCAPE 145
10.1 OVERVIEW 145
10.2 MARKET SHARE ANALYSIS, TRANSFECTION TECHNOLOGIES MARKET (2014) 146
10.3 COMPETITIVE SITUATION AND TRENDS 148
10.4 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & STRATEGIC ALLIANCES 149
10.5 NEW PRODUCT LAUNCHES 152
10.6 EXPANSIONS 154
10.7 ACQUISITIONS 156
10.8 OTHERS 157
11 COMPANY PROFILES 159
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 INTRODUCTION 159
11.2 THERMO FISHER SCIENTIFIC, INC. (LIFE TECHNOLOGIES) 160
11.3 PROMEGA CORPORATION 163
11.4 QIAGEN N.V. 166
11.5 POLYPLUS TRANSFECTION SA 169
11.6 ROCHE 172
11.7 BIO–RAD LABORATORIES INC. 174
11.8 LONZA GROUP 176
11.9 SIGMA- ALDRICH CORPORATION 179
11.10 MIRUS BIO LLC. 182
11.11 MAXCYTE, INC. 184

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
12 APPENDIX 185
12.1 DISCUSSION GUIDE 185
12.2 COMPANY DEVELOPMENTS (2012-2015) 190
12.2.1 THERMO FISHER SCIENTIFIC, INC. 190
12.2.2 PROMEGA CORPORATION 191
12.2.3 QIAGEN N.V. 191
12.2.4 SIGMA-ALDRICH CORPORATION 192
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 193
12.4 AVAILABLE CUSTOMIZATIONS 193
12.5 RELATED REPORTS 194
?